TNFRSF12A and pancreatic adenocarcinoma: Importantly, a high expression of TNFRSF12A is associated with more aggressive PAAD, illustrated by the significantly shorter patient survival compared with the low TNFRSF12A expression group (Figure 1B; n(high) = 45, n(low) = 45, Logrank p = 0.0041).